Patents by Inventor Sang-Yull Lee

Sang-Yull Lee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Human sarcoma-associated antigens
    Patent number: 8252903
    Abstract: The invention relates to sarcoma-associated antigens and the nucleic acid molecules that encode them. The invention further relates to the use of the nucleic acid molecules, polypeptides and fragments thereof associated with sarcoma in methods and compositions for the diagnosis and treatment of diseases, such as cancer. More specifically, the invention relates to the discovery of a novel cancer/testis (CT) antigen, NY-SAR-35.
    Type: Grant
    Filed: January 6, 2010
    Date of Patent: August 28, 2012
    Assignee: Ludwig Institute for Cancer Research
    Inventors: Matthew J. Scanlan, Cynthia H. Scanlan, legal representative, Sang-Yull Lee, Lloyd J. Old
  • HUMAN SARCOMA-ASSOCIATED ANTIGENS
    Publication number: 20100172910
    Abstract: The invention relates to sarcoma-associated antigens and the nucleic acid molecules that encode them. The invention further relates to the use of the nucleic acid molecules, polypeptides and fragments thereof associated with sarcoma in methods and compositions for the diagnosis and treatment of diseases, such as cancer. More specifically, the invention relates to the discovery of a novel cancer/testis (CT) antigen, NY-SAR-35.
    Type: Application
    Filed: January 6, 2010
    Publication date: July 8, 2010
    Applicant: Ludwig Institute for Cancer Research Ltd.
    Inventors: Matthew J. Scanlan, Cynthia H. Scanlan, Sang-Yull Lee, Lloyd J. Old
  • Human sarcoma-associated antigens
    Patent number: 7662917
    Abstract: The invention relates to sarcoma-associated antigens and the nucleic acid molecules that encode them. The invention further relates to the use of the nucleic acid molecules, polypeptides and fragments thereof associated with sarcoma in methods and compositions for the diagnosis and treatment of diseases, such as cancer. More specifically, the invention relates to the discovery of a novel cancer/testis (CT) antigen, NY-SAR-35.
    Type: Grant
    Filed: September 30, 2003
    Date of Patent: February 16, 2010
    Assignee: Ludwig Institute for Cancer Research
    Inventors: Matthew J. Scanlan, Cynthia H. Scanlan, legal representative, Sang-Yull Lee, Lloyd J. Old
  • Human sarcoma-associated antigens
    Patent number: 7560537
    Abstract: The invention relates to sarcoma-associated antigens and the nucleic acid molecules that encode them. The invention further relates to the use of the nucleic acid molecules, polypeptides and fragments thereof associated with sarcoma in methods and compositions for the diagnosis and treatment of diseases, such as cancer. More specifically, the invention relates to the discovery of a novel cancer/testis (CT) antigen, NY-SAR-35.
    Type: Grant
    Filed: September 30, 2002
    Date of Patent: July 14, 2009
    Assignee: Ludwig Institute for Cancer Research
    Inventors: Matthew J. Scanlan, Sang-Yull Lee, Lloyd J. Old
  • Human Sarcoma-Associated Antigens
    Publication number: 20080089888
    Abstract: The invention relates to sarcoma-associated antigens and the nucleic acid molecules that encode them. The invention further relates to the use of the nucleic acid molecules, polypeptides and fragments thereof associated with sarcoma in methods and compositions for the diagnosis and treatment of diseases, such as cancer. More specifically, the invention relates to the discovery of a novel cancer/testis (CT) antigen, NY-SAR-35.
    Type: Application
    Filed: September 30, 2003
    Publication date: April 17, 2008
    Applicant: Ludwig Institute for Cancer Research
    Inventors: Matthew J. Scanlan, Cynthia H. Scanlan, Sang-Yull Lee, Lloyd J. Old
  • Human sarcoma-associated antigens
    Publication number: 20040063101
    Abstract: The invention relates to sarcoma-associated antigens and the nucleic acid molecules that encode them. The invention further relates to the use of the nucleic acid molecules, polypeptides and fragments thereof associated with sarcoma in methods and compositions for the diagnosis and treatment of diseases, such as cancer More specifically, the invention relates to the discovery of a novel cancer/testis (CT) antigen, NY-SAR-35.
    Type: Application
    Filed: September 30, 2002
    Publication date: April 1, 2004
    Inventors: Matthew J. Scanlan, Sang-Yull Lee, Lloyd J. Old